Zealand Pharma A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZEAL.CO | 688166.SS | BMRN | ROIV | ENTX | KLRA | |
|---|---|---|---|---|---|---|
| Market cap | 15.97B | 13.81B | 11.07B | 27.61B | 540.90M | 1.66B |
| P/E (TTM) | 6.2 | 132.1 | — | — | — | — |
| Forward P/E | 33.7 | 53.7 | 9.0 | -27.5 | -5.7 | -3.0 |
| Price/book | 0.9 | 4.5 | 1.8 | 6.5 | 21.2 | 0.0 |
| Dividend yield | — | 0.05% | — | — | — | — |
| 1-year change | −44.17% | −44.06% | +10.20% | +85.85% | 0.00% | −50.77% |
| Today | +1.56% | +2.42% | +2.64% | +6.08% | +1.97% | +1.75% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ZEAL.CO news ›Zealand Pharma A/S (ZLDPF) Expected to Release Earnings on Thursday
Posted by Kim Johansen on Nov 5th, 2026 Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) is anticipated to issue its results before the market opens on Thursday, November 12th. Analysts expect Zealand Pharma A/S to announce earnings of…
Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million
Royalty Pharma plc announced an agreement for $100 million in funding to Zealand Pharma A/S in exchange for Zealand Pharma A/S?s economics related to rusfertide , a potential first-in-class therapy... Royalty Pharma plc announced an…
Member Spotlight: Zealand Pharma A/S
Massachusetts Biotechnology Council Zealand Pharma is a biotechnology company transforming metabolic health so millions of people can live without limits. With the opening of its new research hub at 35 CambridgePark Drive, Zealand Pharma…
Zealand Pharma A/S and Generate Biomedicines Inc. Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with Ai for Metabolic Diseases
Zealand Pharma A/S announced a multi-target strategic collaboration with Generate Biomedicines Inc. . Under the collaboration, the companies intend to design and develop multispecific protein... Zealand Pharma A/S announced a multi-target…
Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)
Posted by Michael Walen on Oct 14th, 2026 Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) and Fractyl Health (NASDAQ:GUTS – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Zealand Pharma A/S Stock (ZEAL) - Quote Nasdaq Copenhagen
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2025, the Group had a portfolio of 8 products in clinical development…
Zealand Pharma A/S: Relative Strength Chart - Stock Nasdaq Copenhagen
Compare Zealand Pharma A/S with the company of your choice via a Relative Strength chart. Real-time ZEAL price, Nasdaq Copenhagen stock exchange Relative Strength Chart Zealand Pharma A/S Biotechnology & Medical Research All financial news…
Zealand Pharma A/S : Insider Transactions
Follow insider transactions on Zealand Pharma A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Zealand Pharma A/S Biotechnology & Medical Research Latest insider…
Zealand Pharma A/S: Latest Headlines - Nasdaq Copenhagen Stock Exchange
Find the latest highlights on Zealand Pharma A/S at the Nasdaq Copenhagen stock exchange. Highlights Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01, 2026 at 07:54 am…
Zealand Pharma A/S: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Zealand Pharma A/S on MarketScreener. Press Releases Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- massbio.org1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.